Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting
10 studies found for:    cardiox
Show Display Options
Rank Status Study
1 Terminated Cardiox Shunt Detection Technology Study
Condition: Patent Foramen Ovale
Intervention: Device: Cardiox FDS
2 Withdrawn Cardiox Liver Function Test Pivotal Trial
Conditions: Hepatic Failure;   Liver Failure
Interventions: Drug: 0.1 mg/kg ICG Dose;   Drug: 0.5 mg/kg ICG dose
3 Terminated Right to Left Cardiac Shunt Detection
Conditions: Right to Left Shunt;   Patent Foramen Ovale;   Atrial Septal Defect
Intervention: Device: Flow Detection System
4 Terminated Liver Function Assessment - Feasibility and Dosing Study
Condition: Hepatic Failure
Intervention: Drug: ICG Dye
5 Recruiting Impact of Hyperoxia During Cardiopulmonary
Condition: Cardiac Complications
Intervention: Drug: medical oxygen
6 Not yet recruiting Evolution of Oxidative Stress in Coronary Patients With Moderate Sleep Apnea Syndrome After Treatment With Continuous Positive Airway Pressure
Conditions: Sleep Apnea Syndrome;   Coronary Artery Disease
Interventions: Device: Continuous positive airway pressure;   Device: Sham-continuous positive airway pressure
7 Not yet recruiting TMJ NextGen Pilot Study to Treat Subjects With Bruxism
Condition: Bruxism
Interventions: Device: TMJ Next Generation;   Device: DSG Relaxer
8 Completed Correlation of Right-left Shunt Detection in Cardioembolism Etiology in Stroke Patient.
Condition: Foramen Ovale Patent
9 Completed TMJ NextGeneration(TM) Feasibility Study
Condition: Bruxism
Intervention: Device: TMJ NextGeneration(TM)
10 Withdrawn TMJ-1001 Bruxism Run-In/Pivotal Trial
Condition: Bruxism
Interventions: Device: TMJ(TM) NextGeneration;   Device: Standard Hard TMJD Splint

Indicates status has not been verified in more than two years